Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility

Meta Gene

Volumn 6, Issue , 2015, Pages 72-84

  Kumar, Pradeep ^a   Yadav, Upendra ^a   Rai, Vandana ^a  

^a VEER BAHADUR SINGH PURVANCHAL UNIVERSITY   (India)

Author keywords

Breast cancer; Folic acid; Meta analysis; MTHFR; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2) GENE; ASIAN; BREAST CANCER; CAUCASIAN; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; META ANALYSIS; POPULATION GENETICS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

EID: 84942588128     PISSN: None     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2015.08.008     Document Type: Review

References (128)

1. Akram M., Malik F.A., Kayani M.A. Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population. Asian Pac. J. Cancer Prev. 2012, 13:1599-1603.
2. Alshatwi A.A. Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR) single nucleotide polymorphisms. Food Chem. Toxicol. 2010, 48:1881-1885.
3. Barbosa Rde C., Menezes D.C., Freire T.F., Sales D.C., Alencar V.H. Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent. Mol. Biol. Rep. 2012, 39:4899-4907.
4. Batschauer A.P., Cruz N.G., Oliveira V.C., Coelho F.F., Santos I.R. HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women. Mol. Cell. Biochem. 2011, 357:247-253.
5. Bax L., Yu L.M., Ikeda N., Tsuruta H., Moons K.G. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med. Res. Methodol. 2006, 6:50.
6. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
7. Bentley A.R., Raiszadeh F., Stover P.J., Hunter D.J., Hankinson S.E. No association between cSHMT genotypes and the risk of breast cancer in the Nurses' Health Study. Eur. J. Clin. Nutr. 2010, 64:108-110.
8. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3290-3295.
9. Boccia S., Boffetta P., Brennan P., Ricciardi G., Gianfagna F., Matsuo K., et al. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett. 2009, 273:55-61.
10. Boccia S., Hung R., Ricciardi G., Gianfagn F., Ebert M.P.A., Fang J.Y., et al. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am. J. Epidemiol. 2008, 167(5):505-516.
11. Cam R., Eroglu A., Egin Y., Akar N. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer. Breast Cancer Res. Treat. 2009, 115:431-432.
12. Campbell I.G., Baxter S.W., Eccles D.M., Choong D.Y. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res. 2002, 4:R14.
13. Cerne J.Z., Pohar-Perme M., Cerkovnik P., Gersak K., Novakovic S. Age at menarche and menopause is not associated with two common genetic variants in the methylenetetrahydrofolate reductase (MTHFR) gene. Eur. J. Contracept. Reprod. Health Care 2011, 16(4):241-247.
14. Chen J., Gammon M.D., Chan W., Palomeque C., Wetmur J.G., Kabat G.C., et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 2005, 65:1606-1614.
15. Cheng C.W., Yu J.C., Huang C.S., Shieh J.C., Fu Y.P., Wang H.W., et al. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res. Treat. 2008, 111:145-155.
16. Chou Y.C., Wu M.H., Yu J.C., Lee M.S., Yang T., Shih H.L., et al. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels, and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis 2006, 27:2295-2300.
17. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997, 350:1047-1059. Collaborative Group on Hormonal Factors in Breast Cancer.
18. Deligezer U., Akisik E.E., Dalay N. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo 2005, 19:889-893.
19. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
20. Diakite B., Tazzite A., Hamzi K., Jouhadi H., Nadifi S. Methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Moroccan women. Afr. Health Sci. 2012, 12(2):204-209.
21. Ding X.P., Feng L., Ma L. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis. Asian Pac. J. Cancer Prev. 2012, 13:3937-3942.
22. Duthie S.J. Folic acid deficiency and cancer: mechanisms of DNA instability. Br. Med. Bull. 1999, 55:578-592.
23. Egger M., Davey S., Schneider G., Minder M.C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
24. Ergul E., Sazci A., Utkan Z., Canturk N.Z. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumor Biol. 2003, 24:286-290.
25. Ericson U., Sonestedt E., Ivarsson M.I., Gullberg B., Carlson J., Olsson H., et al. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol. Biomark. Prev. 2009, 18:1101-1110.
26. Ferlay J., Bray F., Pisani P., Parkin D.M. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5 [CD-ROM]. Version 1.1 2000, IARC Press, Lyon.
27. Forsti A., Angelini S., Festa F., Sanyal S., Zhang Z., Grzybowska E., et al. Single nucleotide polymorphisms in breast cancer. Oncol. Rep. 2004, 11:917-922.
28. Frankenburg F.R. The role of one-carbon metabolism in schizophrenia and depression. Harv. Rev. Psychiatry 2007, 15(4):146-160.
29. Frosst P., Bloom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10:111-113.
30. Gao C.M., Tang J.H., Cao H.X., Ding J.H., Wu J.Z., Wang J., et al. MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J. Hum. Genet. 2009, 5:414-418.
31. Gilbody S., Lewis S., Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am. J. Epidemiol. 2007, 165(1):1-13.
32. Goodman J.E., Lavigne J.A., Wu K., Helzlsouer K.J., Strickland P.T., Selhub J., et al. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis 2001, 22(10):1661-1665.
33. Grieu F., Powell B., Beilby J., Iacopetta B. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype. Anticancer Res. 2004, 24:3215-3219.
34. Guo J., Jin M., Zhang M., Chen L.A. Genetic variant in miR-196a2 increased digestive system cancer risks: a meat-analysis of 15 case-control studies. PLoS ONE 2012, 7(1):e30585.
35. He J.M., Pu Y.D., Wu Y.J., Qin R., Zhang Q.J., Sun Y.S., et al. Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer. Genet. Mol. Res. 2014, 13(4):8925-8931.
36. Hekim N., Ergen A., Yaylim I., Yilmaz H., Zeybek U., Oztürk O., et al. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem. Funct. 2007, 25:115-117.
37. Hennquez-Hernandez L.A., Murias-Rosales A., Hernandez Gon-zalez A., Cabrera De Leon A., Diaz-Chico B.N., Mori De Santiago M., et al. Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol. Rep. 2009, 22:1425-1433.
38. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
39. Holmes M.V., Newcombe P., Hubacek J.A., Sofat R., Ricketts S.L., Cooper J., et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomized trials. Lancet 2011, 378:584-594.
40. Hosseini M., Houshmand M., Ebrahimi A. MTHFR polymorphisms and breast cancer risk. Arch. Med. Sci. 2011, 7:134-137.
41. Hua Z., Wang Y., Ni J., Ge F., Zou T. Serum folate, vitamin B12 concentration and MTHFR, MS gene polymorphism associated with risk of breast cancer research. Mod. Oncol. 2011, 19:L428-L431.
42. Huang C.Y., Chang W.S., Shui H.A., Hsieh Y.H., Loh C.H., Wang H.C., et al. Evaluation of the contribution of methylenetetrahydrofolate reductase genotypes to Taiwan breast cancer. Anticancer Res. 2014, 34:4109-4115.
43. 2 index?. Psychol. Methods 2006, 11:193-206.
44. Hulka B.S., Stark A.T. Breast cancer: cause and prevention. Lancet 1995, 346:883-887.
45. Inoue M., Robien K., Wang R., Van Den Berg D.J., Koh W.P., Yu M.C. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese health study. Carcinogenesis 2008, 29:1967-1972.
46. Jakubowska A., Rozkrut D., Antoniou A., Hamann U., Scott R.J., McGuffog L., et al. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br. J. Cancer 2012, 106:2016-2024.
47. Jiang-Hua Q., De-Chuang J., Zhen-Duo L., Shu-de C., Zhenzhen L. Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes. Tumor Biol. 2014, 35(12):11895-11901.
48. Jin Z.Z., Lu Q., Ge D.H., Zong M., Zhu Q.H. Effect of the methylenetetrahydrofolate reductase gene C677T polymorphism on C-erbB-2 methylation status and its association with cancer. Mol. Med. Rep. 2009, 2:283-289.
49. Justenhoven C., Hamann U., Pierl C.B., Rabstein S., Pesch B. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol. Biomark. Prev. 2005, 14:3015-3018.
50. Kakkoura M.G., Demetriou C.A., Loizidou M.A., Loucaides G., Neophytou I., Marcou Y., Hadjisavvas A., et al. Single-nucleotide polymorphisms in one-carbon metabolism genes, Mediterranean diet and breast cancer risk: a case-control study in the Greek-Cypriot female population. Genes Nutr. 2015, 10(2):453.
51. Kalemi T.G., Lambropoulos A.F., Gueorguiev M., Chrisafi S., Papazisis K.T. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett. 2005, 222:57-65.
52. Kalyankumar C., Jamil K. Methylene tetrahydofolate reductase (MTHFR) C677T and A1298C polymorphisms and breast cancer in South Indian population. Int. J. Cancer Res. 2006, 2:143-151.
53. Kan X., Zou T., Wu X., Wang X. Yunnan methylenetetrahydrofolate reductase gene polymorphism associated with breast cancer susceptibility. Cancer Res. 2007, 34:716-718.
54. Kang S.S., Zhou J., Wong P., Kowalisyn J., Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 1988, 43:414.
55. Kelsey J.L. Breast cancer epidemiology: summary and future directions. Epidemiol. Rev. 1993, 15:256-263.
56. Kim Y.I. Folate and carcinogenesis: evidence, mechanisms, and implications. J. Nutr. Biochem. 1999, 10:66-88.
57. Kotsopoulos J., Zhang W.W., Zhang S., McCready D., Trudeau M., Zhang P., et al. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res. Treat. 2008, 8:9895-9896.
58. Laanpere M., Altmäe S., Stavreus-Evers A., Nilsson T.K., Yngve A., Salumets A. Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability. Nutr. Rev. 2010, 68(2):99-113.
59. Lajin B., Sakur A.A., Ghabreau L., Alachkar A. Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumor Biol. 2012, 33:1133-1139.
60. Langsenlehner U., Krippl P., Renner W., Yazdani-Biuki B., Wolf G., Wascher T.C., et al. The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res. Treat. 2003, 81:169-172.
61. Langsenlehner T., Renner W., Yazdani-Biuki B., Langsenlehner U. Methylenetetrahydrofolatereductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res. Treat. 2008, 107:459-460.
62. Le Marchand L., Haiman C.A., Wilkens L.R., Kolonel L.N., Henderson B.E. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol. Biomark. Prev. 2004, 13:2071-2077.
63. Lee S.A., Kang D., Nishio H., Lee M.J., Kim D.H., Han W., et al. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp. Mol. Med. 2004, 36:116-121.
64. Li W.D., Chen S.Q. Association of methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk. J. Prac. Med. 2009, 25:2031-2033.
65. Li K., Li W., Dong X. Association of 677 C>T (rs1801133) and 1298A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies. PLoS ONE 2014, 9:e71290.
66. Liang H., Yan Y., Li T., Li R., Li M., Li S., et al. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies. Tumor Biol. 2014, 35:1695-1701.
67. Lin W., Cen Y.L., Lin Y., Su F.X., Wu B.H., Tang L.Y., et al. Joint effects between urinary selenium and polymorphisms in methylation related genes on breast cancer risk. Neoplasma 2015, (Epub ahead of print: DOI:10.4149/neo_2015_059).
68. Lin W.Y., Chou Y.C., Wu M.H., Huang H.B., Jeng Y.L., Wu C.C., et al. The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan. Anticancer Res. 2004, 24:3863-3868.
69. Lissowska J., Gaudet M.M., Brinton L.A., Chanock S.J., Peplonska B. Genetic polymorphisms in the one carbon metabolism pathway and breast cancer risk: a population-based case-control study and metaanalyses. Int. J. Cancer 2007, 120:2696-2703.
70. Liu Y., Zhou L.S., Xu X.M., Deng L.Q., Xiao Q.K. Association of dietary intake of folate, vitamin B6 and B12 and MTHFR genotype with breast cancer risk. Asian Pac. J. Cancer Prev. 2013, 14:5189-5192.
71. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 2003, 33(2):177-182.
72. López-Cortés A., Echeverría C., Oña-Cisneros F., Sánchez M.E., Herrera C., Cabrera-Andrade A., et al. Breast cancer risk associated with gene expression and genotype polymorphisms of the folate-metabolizing MTHFR gene: a case-control study in a high altitude Ecuadorian mestizo population. Tumor Biol. 2015, (Epub ahead of print: DOI 10.1007/s13277-015-3335-0).
73. Lu Q., Jiang K., Li Q., Ji Y.J., Chen W.L., Xue X.H. Polymorphisms in the MTHFR gene are associated with breast cancer risk and prognosis in a Chinese population. Tumor Biol. 2015, (Epub ahead of print: DOI 10.1007/s13277-014-3016-4).
74. Ma E., Iwasaki M., Junko I., Hamada G.S., Nishimoto I.N. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 2009, 9:122.
75. Ma E., Iwasaki M., Kobayashi M., Kasuga Y., Yokoyama S., Onuma H., et al. Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case control study in Japan. Nutr. Cancer 2009, 61:447-456.
76. Macis D., Maisonneuve P., Johansson H., Bonanni B., Botteri E., Iodice S., et al. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res. Treat. 2007, 106:263-271.
77. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
78. Maruti S.S., Ulrich C.M., Jupe E.R., White E. MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res. 2009, 11:R9.
79. Mei Q., Zhou D., Gao J., Shen S., Wu J., Guo L., et al. The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer 2012, 12:467-476.
80. Mir M.M., Dar J.A., Dar N.A., Dar M.S., Salam I., Lone M.M., et al. Combined impact of polymorphism of folate metabolism genes; glutamate carboxypeptidase, methylene tetrahydrofolate reductase and methionine synthase reductase on breast cancer susceptibility in Kashmiri women. In. J. Health Sciences. 2008, 2:3-14.
81. Naushad S.M., Reddy C.A., Rupasree Y., Pavani A., Digumarti R.R., Gottumukkala S.R., et al. Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancer. Cell Biochem. Biophys. 2011, 61:715-723.
82. Ozen F., Erdis E., Sik E., Silan F., Uludag A., Ozdemir O. Germ-line MTHFR C677T, FV H1299R and PAI-1 5G/4G variations in breast carcinoma. Asian Pac. J. Cancer Prev. 2013, 14:2903-2908.
83. Platek M.E., Shields P.G., Marian C., McCann S.E., Bonner M.R., Nie J., et al. Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2009, 18(2459):2453-2459.
84. Prasad V.V., Wilkhoo H. Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie 2011, 34:422-426.
85. van der Put N., van Straaten M., Trijbels H.W., Blom F.J., H.J. Folate, homocysteine and neural tube defects: an overview. Exp. Biol. Med. (Maywood) 2001, 226(4):243-270.
86. Qi X., Ma X., Yang X., Fan L., Zhang Y. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res. Treat. 2011, 123:499-506.
87. Qi J., Miao X.P., Tan W., Yu C.Y., Liang G., Lü W.F., et al. Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of breast cancer. Zhonghua Zhong Liu Za Zhi 2004, 26:287-289.
88. Rai V. Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder. Cell. Mol. Biol. 2011, (Noisy-le-grand). 57, Suppl:OL1558-OL1566.
89. Rai V. The methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Asian populations. Asian Pac. J. Cancer Prev. 2014, 15:5853-5860.
90. Rai V., Yadav U., Kumar P., Yadav S.K., Mishra O.P. Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies. PLoS ONE 2014, 9:e108552.
91. Reljic A., Simundic A.M., Topic E., Nikolac N., Justinic D. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin. Biochem. 2007, 40:981-985.
92. Robien K., Ulrich C.M. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am. J. Epidemiol. 2003, 157(7):571-582.
93. Rohan T.E., Jain M.G., Howe G.R., Miller A.B. Dietary folate consumption and breast cancer risk. J. Natl. Cancer Inst. 2000, 92:266-269.
94. Rosenberg N., Murata M., Ikeda Y., Opare-Sem O., Zivelin A., Geffen E., et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am. J. Hum. Genet. 2002, 70:758-762.
95. Sangrajrang S., Sato Y., Sakamoto H., Ohnami S., Khuhaprema T., Yoshida T. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res. Treat. 2010, 123:885-893.
96. Semenza J.C., Delfino R.J., Ziogas A., Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res. Treat. 2003, 77:217-223.
97. Sen S., Duman R., Sanacora G. Serum BDNF, depression and anti-depressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64(6):527-532.
98. Sharp L., Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am. J. Epidemiol. 2004, 159(5):423-443.
99. Sharp L., Little J., Schofield A.C., Pavlidou E., Cotton S.C., Meidzybrodzka Z., et al. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett. 2002, 181:65-71.
100. Shrubsole M.J., Gao Y.T., Cai Q., Shu X.O., Dai Q., Hébert J.R., et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomark. Prev. 2004, 13:190-196.
101. Singh P., Carlus J., Sekhar D., Francis A., Gupta N., Konwar R., et al. MTHFR 677C>T polymorphism and the risk of breast cancer: evidence from an original study and pooled data for 28031 cases and 31880 controls. PLoS ONE 2015, 10(3):e0120654.
102. Sohn K.J., Jang H., Campan M., Weisenberger D.J., Dickhout J., Wang Y.C., et al. The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification. Int. J. Cancer 2009, 124:1999-2005.
103. Stern L.L., Mason J.B., Selhub J., Choi S.W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomark. Prev. 2000, 9:849-853.
104. Stevens V.L., McCullough M.L., Pavluck A.L., Talbot J.T., Feigelson H.S., Thun M.J., et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol. Biomark. Prev. 2007, 16:1140-1147.
105. Sturgeon S.R., Schairer C., Grauman D., El Ghormli L., Devesa S. Trends in breast cancer mortality rates by region of the United States, 1950-1999. Cancer Causes Control 2004, 15:987-995.
106. Suzuki T., Matsuo K., Hirose K., Hiraki A., Kawase T., Watanabe M., et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008, 2:356-362.
107. Tu Y.L., Wang S.B., Tan X.L. MTHFR gene polymorphisms are not involved in pancreatic cancer risk: a meta-analysis. Asian Pac. J. Cancer Prev. 2012, 13:4627-4630.
108. Ueland P.M., Hustad S., Schneede J., Refsum H., Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci. 2001, 22:195-201.
109. Vainer A.S., Boiarskikh U.A., Voronina E.N., Selezneva I.A., Sinkina T.V. Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia. Mol. Biol. (Mosk) 2010, 44:816-823.
110. Wallace B.C., Dahabreh I.J., Trikalinos T.A., Lau J., Trow P., Schmid C.H. Closing the gap between methodologists and end-users: R as a computational back-end. J. Stat. Softw. 2013, 49:1-15.
111. Wang Z.G., Cui W., Yang L.F., Zhu Y.Q., Wei W.H. Association of dietary intake of folate and MTHFR genotype with breast cancer risk. Genet. Mol. Res. 2014, 13:5446-5451.
112. Weiwei Z., Liping C., Dequan L. Association between dietary intake of folate, vitamin B6, B12 & MTHFR, MTR genotype and breast cancer risk. Pak. J. Med. Sci. 2014, 30:106-110.
113. Wen Y.Y., Yang S.J., Zhang J.X., Chen X.Y. Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies. Asian Pac. J. Cancer Prev. 2013, 14:21-25.
114. Wilcken B., Bamforth F., Li Z., Zhu H., Ritvanen A., Renlund M., et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J. Med. Genet. 2003, 40(8):619-625.
115. Wu X.Y., Ni J., Xu W.J., Zhou T., Wang X. Interactions between MTHFR C677T-A1298C variants and folic acid deficiency affect breast cancer risk in a Chinese population. Asian Pac. J. Cancer Prev. 2012, 13:2199-2206.
116. Wu Y., Yuan X., Zheng H., et al. Northeast methylenetetrahydrofolate reductase gene c677t single nucleotide polymorphisms and susceptibility to breast cancer research. Mod. Oncol. 2010, 18:2375-2378.
117. Xu X., Gammon M.D., Zhang H., Wetmur J.G., Rao M. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 2007, 28:1504-1509.
118. Yadav U., Kumar P., Rai V. Global prevalence of MTHFR C677T gene polymorphism: a meta-analysis of population based studies. Indian J. Clin. Biochem. 2014, 29(1):123-124.
119. Yadav U., Kumar P., Yadav S.K., Mishra O.P., Rai V. Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab. Brain Dis. 2015, 30:7-14.
120. Yang X., Lippman M.E. BRCA1 and BRCA2 in breast cancer. Breast Cancer Res. Treat. 1999, 54:1-10.
121. Yu L., Chen J. Association of MHTFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: an update meta-analysis based on 51 research studies. Diagn. Pathol. 2012, 7:171.
122. Yu C.P., Wu M.H., Chou Y.C., Yang T., You S.L., Chen C.J., et al. Breast cancer risk associated with multigenotypic polymorphisms in folate metabolizing genes: a nested case-control study in Taiwan. Anticancer Res. 2007, 27:1727-1732.
123. Yuan H., Xu X.Y., Wang Z.L. The relation between polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of breast cancer. J. MuDan Jiang Med. Univ. 2009, 30:2-4.
124. Zhang S., Hunter D.J., Hankinson S.E., Giovannucci E.L., Rosner B.A., et al. A prospective study of folate intake and the risk of breast cancer. J. Am. Med. Assoc. 1999, 281:1632-1637.
125. Zhang T., Lou J., Zhong R., Wu J., Zou L., Sun Y., et al. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS ONE 2013, 8:e59570.
126. Zhang J., Qiu L.X., Wang Z.H., Wu X.H., Liu X.J. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Res. Treat. 2010, 123:549-555.
127. Zhang W.B., Zhang J.H., Pan Z.Q., Yang Q.S., Liu B. The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls. Asian Pac. J. Cancer Prev. 2012, 13:2597-2604.
128. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin. Genet. 2006, 69:327-336.